One important metric to look for in a stock is an 80 or higher Relative Strength Rating. CME Group Cl A now clears that threshold, with a jump from 77 to 83 Tuesday.
Hone Your Stock-Picking Skills By Focusing On These Factors
IBD's proprietary RS Rating identifies market leadership by using a 1 (worst) to 99 (best) score that shows how a stock's price action over the trailing 52 weeks matches up against the rest of the market.
History reveals that the stocks that go on to make the biggest gains tend to have an 80 or better RS Rating as they begin their biggest climbs.
CME Group Cl A is building a flat base with a 290.79 entry. See if it can break out in volume at least 40% above average.
Earnings grew 12% last quarter, up from 6% in the prior report. Revenue also increased, from 6% to 10%. The company is expected to report its latest earnings and sales numbers on or around Jul. 23.
CME Group Cl A earns the No. 9 rank among its peers in the Financial Services-Specialty industry group. X Financial ADR, IREN and Jiayin Group ADR are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Which Stocks Are Showing Improved Technical Action?
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
